|
QuintilesIMS Real-World Insights Bibliography
| Patient database analysis of fulvestrant 500 mg in the treatment of metastatic breast cancer: A European perspective |
| Author(s): Marchetti P1, Maass N2, Gligorov J3, Berger K4, MacDougall F5, Montonen J6, Lewis J6. |
| Affiliations(s): Department of Clinical and Molecular Medicine, Sapienza University of Rome and IDI-IRCCS, Rome, Italy. Electronic address: paolo.marchetti@ospedalesantandrea.it.
2
Department of Gynecology and Obstetrics, University Medical Center Schleswig-Holstein, Kiel, Germany.
3
Department of Medical Oncology, INSERM U938, APHP Tenon, IUC-UPMC, Sorbonne University, Paris, France.
4
Real World Evidence Solutions and HEOR, IMS Health, Munich, Germany.
5
Real World Evidence Solutions and HEOR, IMS Health, London, United Kingdom.
6
AstraZeneca, London, United Kingdom. |
| Publication(s): Breast. 2017 Apr;32:247-255. |
| Document Type(s): Article |
| Countries: France, Germany, Italy, Spain |
| Click here for the abstract |
C:
Y: |
Oncology
2017 |
|
L:
A: |
English
clinical setting: Secondary care, Retrospective database analysis |
|
 |
| |
| |
| Assessment of Public Health and Economic Impact of Intranasal Live-Attenuated Influenza Vaccination of Children in France Using a Dynamic Transmission Model. |
| Author(s): Gerlier L1, Lamotte M1, Grenèche S2, Lenne X3, Carrat F4,5, Weil-Olivier C6, et al. |
| Affiliations(s): 1 QuintilesIMS, Zaventem, Belgium 2 AstraZeneca, Rueil-Malmaison, France 3 University Lille Nord de France, Lille, France 4 Sorbonne Universités, Paris, France 5 Saint-Antoine Hospital, Paris, France 6 University Paris VII, Paris, France |
| Publication(s): Appl Health Econ Health Policy, 2017, Apr, 15(2): 261-276 |
| Document Type(s): Abstract |
| Countries: France |
| Click here for the abstract |
C:
Y: |
Infectious disease
2017 |
|
L:
A: |
English
|
|
|
| |
| |
| COST OF VISITS ASSOCIATED WITH MANAGEMENT OF INTERNATIONAL NORMALIZED RATIO (INR) RESULTS IN ATRIAL FIBRILLATION (AF) PATIENTS TREATED WITH VITAMIN K ANTAGONIST (VKA) |
| Author(s): Ansolabehere X1, Augier G2 |
| Affiliations(s): 1QuintilesIMS, Paris La Défense, France, 2Axess Research, Limonest, France |
| Publication(s): 22nd international ISPOR, Boston 2017 |
| Document Type(s): Poster |
| Countries: France |
| Click here for the abstract |
C:
Y: |
Health economics
2017 |
|
L:
A: |
English
Clinical setting: Primary care, Cost analysis, Survey research |
|
|
| |
| |
| Multicenter evaluation of Time, Operational and Economic Efficiencies of a New Pre-loaded IOL delivery system vs manual IOL delivery |
| Author(s): Mendicute J1, Pablo L2, Vélasque L3, Martinez A4, Asmar J5, Schweitzer C6 |
| Affiliations(s): 1.Hospital Universitario Donostia Servicio de Oftalmología
2.Hospital Universitario Miguel Servet Servicio de Oftalmología
3.Centre Retine Gallien Bordeaux
4.Alcon Laboratories, Inc., Fort Worth, TX
5.IMS Health Information Solutions France
6.Department of Ophthalmology, Bordeaux University Hospital, France
|
| Publication(s): ASCRS (cataract congress) |
| Document Type(s): Abstract, Poster |
| Countries: France |
C:
Y: |
Ophthalmology
2017 |
|
L:
A: |
English
Cost effectiveness, Observational study, Prospective study |
|
|
| |
| |
| Etude DISCOVER France - étude enrichie visant à décrire la prise en charge des patients diabétiques de type 2 |
| Author(s): Harmand S.1, Maillard C.1, Thomas F.2 |
| Affiliations(s): 1. QuintilesIMS, La Défense, France. 2. Astra Zeneca, La Défense, France
|
| Publication(s): ADELF-SFSP congress (l'Association des épidémiologistes de langue française - Société française de santé publique) June 2017 in France |
| Document Type(s): Abstract, Poster |
| Countries: France |
C:
Y: |
Diabetes
2017 |
|
L:
A: |
French
Clinical setting: Primary care, Longitudinal study, Observational study, Patient questionnaire, Quality of life, Real World Data |
|
|
| |
| |
| TREATMENT PATTERNS OF METASTATIC MELANOMA IN FIVE EUROPEAN COUNTRIES |
| Author(s): Burudpakdee C1, Zhao Z2, Seetasith A1, Ma Q2, Campos Tapias I3, Barber BL2 |
| Affiliations(s): 1 MS Health, Fairfax, VA, USA, 2 Amgen Inc, Thousand Oaks, CA, USA, 3 Amgen SA, Barcelona, Spain |
| Publication(s): ISPOR 21st, May 2016 Washington, USA |
| Document Type(s): Poster |
| Countries: France, Germany, Italy, Spain, UK |
C:
Y: |
Oncology
2016 |
|
L:
A: |
English
Retrospective database analysis |
|
|
| |
| |
| Stage-specific survival and recurrence in patients with cutaneous malignant melanoma in Europe - a systematic review of the literature. |
| Author(s): Svedman FC1, Pillas D2, Taylor A2, Kaur M2, Linder R3, Hansson J1. |
| Affiliations(s): 1Department of Oncology-Pathology, Karolinska Institutet, Karolinska University Hospital Solna, Stockholm, Sweden.
2Centre for Observational Research, Amgen Ltd, Uxbridge, UK.
3IMS Health Sweden, Stockholm, Sweden.
|
| Publication(s): Clinical Epidemiology |
| Document Type(s): Article |
| Countries: Australia, Austria, Belgium, Bulgaria, Croatia, Czech, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Israel, Italy, Netherlands, Norway, Poland, Portugal, Russian Federation, Serbia and Montenegro, Slovakia, Slovenia, Spain, Sweden, Switzerland, Turkey, UK |
| Click here for the abstract |
C:
Y: |
Oncology
2016 |
|
L:
A: |
English
Literature Review |
|
|
| |
| |
| TREATMENT INDICATIONS FOR ANTIDEPRESSANTS PRESCRIBED IN PRIMARY CARE IN FRANCE, 2006-2015 |
| Author(s): Schwalm MS, Miotti H, Hellard C, Nounit L, Trehony J, Jouaville SL |
| Affiliations(s): IMS HEALTH, Boulogne Billancourt, France |
| Publication(s): ISPOR 19th Annual European Congress, 2016, 29 October-2 November, Vienna, Austria. |
| Document Type(s): Abstract |
| Countries: France |
C:
Y: |
Clinical practice, Mental health
2016 |
|
L:
A: |
English
Clinical setting: Primary care, Retrospective database analysis |
|
|
| |
| |
| Rationale and design of a multi-center survey to evaluate productivity losses and indirect costs after cardiovascular events in Europe. |
| Author(s): Gerlier L1, Sidelnikov E2, Kutikova L2, Lamotte M1, Annemans L3 |
| Affiliations(s): 1 QuintilesIMS, Zaventem, Belgium 2 Amgen (Europe) GmbH, Zug, Switzerland 3 University of Ghent, Ghent, Belgium |
| Publication(s): 19th ISPOR Annual European Congress, 2016, October 29- November 2, Vienna, Austria |
| Document Type(s): Abstract |
| Countries: Belgium, Czech, France, Germany, Hungary, Italy, Poland, Portugal, Romania, Spain, Switzerland, UK |
C:
Y: |
Cardiovascular disease
2016 |
|
L:
A: |
English
|
|
|
| |
| |
| Three-monthly long-acting formulation of paliperidone palmitateis a dominant treatment option, cost saving while adding QALYs, compared to the one-monthly formulation in the treatment of schizophrenia in France. |
| Author(s): Arteaga Duarte C1, Colin X2, De Moor R1, Guillon P3, van Gils CW1
|
| Affiliations(s): 1 QuintilesIMS, Zaventem, Belgium, 2 QuintilesIMS, La Défense, France, 3 Janssen-Cilag France, Issy-les-Moulineaux, Cedex, France |
| Publication(s): 19th ISPOR Annual European Congress, 2016, October 29- November 2, Vienna, Austria |
| Document Type(s): Abstract |
| Countries: France |
C:
Y: |
Mental health
2016 |
|
L:
A: |
English
Methodology |
|
|
| |
| |
 1 of 24 
|
|
